Cargando…
A Novel Oncolytic Herpes Simplex Virus Type 2 Has Potent Anti-Tumor Activity
Oncolytic viruses are promising treatments for many kinds of solid tumors. In this study, we constructed a novel oncolytic herpes simplex virus type 2: oHSV2. We investigated the cytopathic effects of oHSV2 in vitro and tested its antitumor efficacy in a 4T1 breast cancer model. We compared its effe...
Autores principales: | Zhao, Qian, Zhang, Wen, Ning, Zhifeng, Zhuang, Xiufen, Lu, Haizhen, Liang, Jing, Li, Jie, Zhang, Yu, Dong, Ying, Zhang, Youhui, Zhang, Shuren, Liu, Shangmei, Liu, Binlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966855/ https://www.ncbi.nlm.nih.gov/pubmed/24671154 http://dx.doi.org/10.1371/journal.pone.0093103 |
Ejemplares similares
-
Doxorubicin-enriched, ALDH(br) mouse breast cancer stem cells are treatable to oncolytic herpes simplex virus type 1
por: Zhuang, Xiufen, et al.
Publicado: (2012) -
Inhibition of colorectal cancer liver metastasis in BALB/c mice following intratumoral injection of oncolytic herpes simplex virus type 2 for the induction of specific antitumor immunity
por: Zhang, Wen, et al.
Publicado: (2019) -
Stability and anti-tumor effect of oncolytic herpes simplex virus type 2
por: Wang, Yang, et al.
Publicado: (2018) -
Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
por: Suzuki, Takuma, et al.
Publicado: (2021) -
A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4
por: Zhang, Wen, et al.
Publicado: (2015)